Christopher P. Wardell
- Molecular Biology top 5%
- Hematology top 0.5%
- Oncology top 5%
- Cancer Research top 5%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Gareth J. MorganBrian A. WalkerFaith E. DaviesMartin KaiserLaura ChiecchioKevin BoydLorenzo MelchorFiona M. Ross
- Topics
- Multiple Myeloma Research and Treatments (47 papers)Protein Degradation and Inhibitors (21 papers)Cancer Genomics and Diagnostics (14 papers)
- Cited by
- HematologyMolecular BiologyOncology
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Christopher P. Wardell
66 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 1.8k
- Hematology 1.5k
- Oncology 660
- Cancer Research 353
- Pathology and Forensic Medicine 245
Countries citing papers authored by Christopher P. Wardell
This map shows the geographic impact of Christopher P. Wardell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Wardell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Wardell more than expected).
Fields of papers citing papers by Christopher P. Wardell
This network shows the impact of papers produced by Christopher P. Wardell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Wardell. The network helps show where Christopher P. Wardell may publish in the future.
Co-authorship network of co-authors of Christopher P. Wardell
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Wardell. A scholar is included among the top collaborators of Christopher P. Wardell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Wardell. Christopher P. Wardell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 15 | |
| 5 | 3 | |
| 6 | 6 | |
| 7 | 103 | |
| 8 | 22 | |
| 9 | 2 | |
| 10 | 69 | |
| 11 | 7 | |
| 12 | 100 | |
| 13 | 9 | |
| 14 | 204 | |
| 15 | 35 | |
| 16 | 18 | |
| 17 | 33 | |
| 18 | 131 | |
| 19 | 50 | |
| 20 | 224 |
About Christopher P. Wardell
Christopher P. Wardell is a scholar working on Hematology, Cancer Research and Genetics, having authored 69 papers that have together received 2.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (47 papers), Protein Degradation and Inhibitors (21 papers) and Cancer Genomics and Diagnostics (14 papers). The work is most often cited by research in Hematology (1.5k citations), Molecular Biology (1.8k citations) and Oncology (660 citations). Christopher P. Wardell has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Gareth J. Morgan, Brian A. Walker, Faith E. Davies, Martin Kaiser, Laura Chiecchio, Kevin Boyd, Lorenzo Melchor, Fiona M. Ross, David C. Johnson and Annamaria Brioli. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.